Recent Chemotherapy Reduces the Sensitivity of [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography in the Detection of Colorectal Metastases

Recent Chemotherapy Reduces the Sensitivity of [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography in the Detection of Colorectal Metastases

[18F]2-fluoro-2-deoxyglucose (FDG) -positron emission tomography (PET) has become a useful tool in the assessment of patients with colorectal cancer. Patients often undergo chemotherapy as treatment for primary or metastatic colorectal malignancy. Because cytotoxic chemotherapy may decrease the cell...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Egile Nagusiak:	Timothy Akhurst, Tara J. Kates, Madhu Mazumdar, Henry Yeung, Elyn Riedel, Bryan M. Burt, Leslie H. Blumgart, William R. Jarnagin, Steven M. Larson, Yuman Fong
Formatua:	Artigo
Hizkuntza:	ingelesa
Argitaratua:	2005
Sarrera elektronikoa:	https://doi.org/10.1200/jco.2005.04.4222 https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.04.4222?role=tab
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak

Value of<sup>18</sup>Fluorodeoxyglucose–Positron-Emission Tomography in Amyotrophic Lateral Sclerosis
nork: Koen Van Laere, et al.
Argitaratua: (2014)

Intensity of<sup>18</sup>Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s Lymphoma
nork: Heiko Schöder, et al.
Argitaratua: (2005)

Imaging Atherosclerotic Plaque Inflammation With [ <sup>18</sup> F]-Fluorodeoxyglucose Positron Emission Tomography
nork: James H.F. Rudd, et al.
Argitaratua: (2002)

<sup>18</sup>F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
nork: Carla Casulo, et al.
Argitaratua: (2013)

<sup>18</sup> F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma
nork: Rakesh Kumar, et al.
Argitaratua: (2006)

Myocarditis in systemic lupus erythematosus diagnosed by<sup>18</sup>F-fluorodeoxyglucose positron emission tomography
nork: Alexandra Perel-Winkler, et al.
Argitaratua: (2018)

[<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors
nork: Douglas S. Hawkins, et al.
Argitaratua: (2005)

Lung <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Pulmonary Arterial Hypertension
nork: Glenn Marsboom, et al.
Argitaratua: (2012)

Emerging role of<sup>18</sup>F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma
nork: Sang Mi Lee, et al.
Argitaratua: (2019)

Automated Lugano Metabolic Response Assessment in <sup>18</sup> F-Fluorodeoxyglucose–Avid Non-Hodgkin Lymphoma With Deep Learning on <sup>18</sup> F-Fluorodeoxyglucose–Positron Emission Tomography
nork: Skander Jemaa, et al.
Argitaratua: (2024)

Metabolic Assessment of Gliomas Using<sup>11</sup>C-Methionine, [<sup>18</sup>F] Fluorodeoxyglucose, and<sup>11</sup>C-Choline Positron-Emission Tomography
nork: Tomohiro Kato, et al.
Argitaratua: (2008)

Comparison of magnetic resonance angiography and<sup>18</sup>F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis
nork: Kaitlin A. Quinn, et al.
Argitaratua: (2018)

Diagnosis of Infective Endocarditis by Subtype Using <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
nork: Tom Kai Ming Wang, et al.
Argitaratua: (2020)

Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of<sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography
nork: Rakesh Kumar, et al.
Argitaratua: (2008)

The role of <sup>18</sup>F‐fluorodeoxyglucose–positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis
nork: Kwang‐Hoon Lee, et al.
Argitaratua: (2011)

<sup>18</sup>Fluorodeoxyglucose Positron Emission Tomography Studies in Presumed Alzheimer Cases, Including 13 Serial Scans
nork: Edith G. McGeer, et al.
Argitaratua: (1990)

<sup>18</sup> F-Fluoride and <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic Stroke
nork: Alex Vesey, et al.
Argitaratua: (2017)

[<sup>18</sup>F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung Cancer
nork: Ryohei Sasaki, et al.
Argitaratua: (2005)

Carotid Plaque Inflammation Imaged by <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography and Risk of Early Recurrent Stroke
nork: Peter J. Kelly, et al.
Argitaratua: (2019)

[<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography for Detection of Bone Marrow Involvement in Children and Adolescents With Hodgkin's Lymphoma
nork: Sandra Purz, et al.
Argitaratua: (2011)

Use of <sup>18</sup>F-2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer
nork: Mohammad Rashidian, et al.
Argitaratua: (2015)

The clinical application of <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer
nork: Hiroyuki Kato, et al.
Argitaratua: (2009)

The Significance and Management of Incidental [<sup>18</sup>F]Fluorodeoxyglucose–Positron-Emission Tomography Uptake in the Thyroid Gland in Patients with Cancer
nork: Jean Anderson Eloy, et al.
Argitaratua: (2009)

[<sup>18</sup>F] Fluorodeoxyglucose–Positron-Emission Tomography and MR Imaging Coregistration for Presurgical Evaluation of Medically Refractory Epilepsy
nork: K.K. Lee, et al.
Argitaratua: (2009)

<sup>18</sup>F‐fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma
nork: Beom Kyung Kim, et al.
Argitaratua: (2011)

<sup>18</sup>F‐Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma
nork: Akram Al‐Ibraheem, et al.
Argitaratua: (2012)

Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [<sup>18</sup>F]Fluorodeoxyglucose and [<sup>18</sup>F]Fluorothymidine Positron Emission Tomography
nork: Thomas Zander, et al.
Argitaratua: (2011)

Improving the Diagnostic Performance of <sup>18</sup> F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve Endocarditis
nork: Laurens E. Swart, et al.
Argitaratua: (2018)

Prospective Study of [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma
nork: Adam S. Kibel, et al.
Argitaratua: (2009)

Diagnostic Accuracy of Amyloid versus<sup>18</sup>F‐Fluorodeoxyglucose Positron Emission Tomography in<scp>Autopsy‐Confirmed</scp>Dementia
nork: Orit H. Lesman‐Segev, et al.
Argitaratua: (2020)

Prognostic significance of [<sup>18</sup>F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma
nork: Takashi Ohtsuka, et al.
Argitaratua: (2006)

Better Yield of <sup>18</sup>Fluorodeoxyglucose-Positron Emission Tomography in Patients with Metastatic Differentiated Thyroid Carcinoma during Thyrotropin Stimulation
nork: Karin M. van Tol, et al.
Argitaratua: (2002)

[ <sup>18</sup> F]Fluorodeoxyglucose Single Photon Emission Computed Tomography
nork: Gopal Srinivasan, et al.
Argitaratua: (1998)

Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography
nork: Caroline Rousseau, et al.
Argitaratua: (2006)

<sup>18</sup> F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis
nork: Peter C. Grayson, et al.
Argitaratua: (2017)

Association of <scp><sup>18</sup>F‐Fluorodeoxyglucose</scp>–Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis
nork: Kaitlin A. Quinn, et al.
Argitaratua: (2022)

Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases
nork: Correa-Gallego, Camilo, et al.
Argitaratua: (2015)

Accuracy of Helical Computed Tomography and [<sup>18</sup>F] Fluorodeoxyglucose Positron Emission Tomography for Identifying Lymph Node Mediastinal Metastases in Potentially Resectable Non–Small-Cell Lung Cancer
nork: Francisco Pozo-Rodrı́guez, et al.
Argitaratua: (2005)

Brain <scp><sup>18</sup>F</scp>‐fluorodeoxyglucose positron emission tomography: An efficient tool at the initial diagnosis of nonlesional late onset epilepsy
nork: Salomé Puisieux, et al.
Argitaratua: (2025)

Metabolic Activity of the Spleen and Bone Marrow in Patients With Acute Myocardial Infarction Evaluated by <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomograpic Imaging
nork: Eung Ju Kim, et al.
Argitaratua: (2014)